Novavax, Inc. (NVAX)
10.22
-0.12
(-1.16%)
USD |
NASDAQ |
Sep 04, 16:00
10.19
-0.03
(-0.29%)
After-Hours: 20:00
Novavax Cash and Short Term Investments (Annual) : 745.96M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 745.96M |
| December 31, 2024 | 933.74M |
| December 31, 2023 | 578.93M |
| December 31, 2022 | 1.347B |
| December 31, 2021 | 1.527B |
| December 31, 2020 | 804.93M |
| December 31, 2019 | 81.77M |
| December 31, 2018 | 102.98M |
| December 31, 2017 | 185.54M |
| December 31, 2016 | 265.79M |
| December 31, 2015 | 265.62M |
| December 31, 2014 | 168.35M |
| December 31, 2013 | 134.48M |
| December 31, 2012 | 45.10M |
| December 31, 2011 | 18.31M |
| December 31, 2010 | 31.68M |
| Date | Value |
|---|---|
| December 31, 2009 | 42.95M |
| December 31, 2008 | 33.90M |
| December 31, 2007 | 46.49M |
| December 31, 2006 | 73.60M |
| December 31, 2005 | 31.89M |
| December 31, 2004 | 17.88M |
| December 31, 2003 | 27.63M |
| December 31, 2002 | 3.005M |
| December 31, 2001 | 20.04M |
| December 31, 2000 | 14.86M |
| December 31, 1999 | 0.732M |
| December 31, 1998 | 1.031M |
| December 31, 1997 | 3.847M |
| December 31, 1996 | 2.982M |
| December 31, 1995 | 4.634M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Moderna, Inc. | 5.80B |
| Merck & Co., Inc. | 14.69B |
| Pfizer Inc. | 13.60B |
| Recursion Pharmaceuticals, Inc. | 747.89M |
| Agenus, Inc. | 2.998M |